(Q54527773)

30 May 2018

title

Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression. (English)

1 reference

30 May 2018

main subject

human papillomavirus 16

1 reference

Zarina J D'Costa

1

1 reference

30 May 2018

Cheng-Mee Leong

2

1 reference

30 May 2018

Justin Shields

3

1 reference

30 May 2018

Charles Matthews

4

1 reference

30 May 2018

Merilyn H Hibma

5

1 reference

30 May 2018

publication date

23 February 2012

1 reference

30 May 2018

Investigational New Drugs

published in

1 reference

30 May 2018

volume

30

1 reference

30 May 2018

page(s)

2236-2251

1 reference

30 May 2018

issue

6

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s10637-012-9803-0

exact match

0 references

cites work

HPV prophylactic vaccination: The first years and what to expect from now.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Chapter 2: The burden of HPV-related cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Human papillomavirus vaccines and the potential for cross-protection between related HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Immune intervention in HPV infections: current progress and future developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Activity of HspE7, a novel immunotherapy, in patients with anogenital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Natural history of cervical squamous intraepithelial lesions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

A flow cytometry-based assay for the measurement of protein regulation of E-cadherin-mediated adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Regulation of the stability of cell surface E-cadherin by the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Indole-3-carbinol activates the ATM signaling pathway independent of DNA damage to stabilize p53 and induce G1 arrest of human mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Potential of 5-aza-2'-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

DNA topoisomerase poisons as antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

The roles of catenins in the cadherin-mediated cell adhesion: functional analysis of E-cadherin-alpha catenin fusion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Placebo-controlled trial of indole-3-carbinol in the treatment of CIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Induction of estradiol metabolism by dietary indole-3-carbinol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Papillomavirus E6 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-012-9803-0

A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.

21 January 2018

1 reference

12 December 2020

Transmembrane control of cadherin-mediated cell adhesion: a 94 kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin

1 reference

12 December 2020

Down-regulation of p21 contributes to apoptosis induced by HPV E6 in human mammary epithelial cells

1 reference

12 December 2020

Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage

1 reference

12 December 2020

Induction of Tumor-Specific CD4+ and CD8+ T-Cell Immunity in Cervical Cancer Patients by a Human Papillomavirus Type 16 E6 and E7 Long Peptides Vaccine

1 reference

12 December 2020

High-throughput real-time quantitative reverse transcription PCR

1 reference

12 December 2020

Cytokine induction and modifying the immune response to human papilloma virus with imiquimod.

1 reference

12 December 2020

Adriamycin activates E-cadherin-mediated cell-cell adhesion in human breast cancer cells.

1 reference

12 December 2020

Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing

1 reference

12 December 2020

Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis

1 reference

12 December 2020

Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells

1 reference

12 December 2020

Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype.

1 reference

12 December 2020

A comparison of cryocauterisation, laser vaporisation and large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia

1 reference

12 December 2020

Human papillomavirus vaccines: who will pay, who will receive, when to administer?

1 reference

12 December 2020

Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance

1 reference

12 December 2020

5-aminolevulinic acid-mediated photodynamic therapy of intraepithelial neoplasia and human papillomavirus of the uterine cervix--a new experimental approach

1 reference

12 December 2020

E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas

1 reference

12 December 2020

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

1 reference

12 December 2020

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

1 reference

12 December 2020

Heterogeneity of malignant cells from a human colonic carcinoma.

1 reference

12 December 2020

Estrogen-mediated down-regulation of E-cadherin in breast cancer cells

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer

1 reference

12 December 2020

Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer

1 reference

12 December 2020

Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action

1 reference

12 December 2020

Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy

1 reference

12 December 2020

Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice

1 reference

12 December 2020

p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression.

1 reference

12 December 2020

10.1007/S10637-012-9803-0

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

22359217

1 reference

30 May 2018